A comprehensive view of Drug Delivery / Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Health Canada approves Remsima SC from Celltrion Healthcare Canada for maintenance therapy in adults with active ulcerative colitis and Crohns disease; the drug was initially approved in 2021 for rheumatoid arthritis treatment

Bristol Myers Squibb announces new data from the long-term DAYBREAK study reinforcing efficacy and safety of Zeposia ozanimod in patients with relapsing forms of multiple sclerosis

FDA grants priority review to AbbVie's SBLA for epcoritamab-bysp, a subcutaneously administered T-cell engaging bispecific antibody for the treatment of adult relapsed or refractory follicular lymphoma; AbbVie and Genmab are co-developing epcoritamab

AstraZeneca ends collaboration with FibroGen on oral anemia drug roxadustat following FDA rejection, returns rights to the drug in the US and several other countries; AstraZeneca retains interest in China and South Korea where the drug has been approved

Catalent upgrades its capsule capacity to 300 million per year, one-third for potent drugs, at its Boston, Massachusetts, facility; the facility is a Global Center of Excellence for spray drying and DPI capsule manufacturing

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count